Deborah de Castro Moreira

Deborah de Castro Moreira

Auto-generated profile, based on publicly available information

Deborah de Castro Moreira

Laboratory of Clinical Virology, State University of Maringá, Maringá, Brazil

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 March 2020 in Reviews in Medical Virology
Verified
Journal Article
Closed access
PDF file
FJFernando A. Jorge
Fernando A. Jorge
MTMateus V. Thomazella
Mateus V. Thomazella
DMDeborah de Castro Moreira
Deborah de Castro Moreira
LLLuciana D. G. Lopes
Luciana D. G. Lopes
JTJorge J. V. Teixeira
Jorge J. V. Teixeira
DBDennis Bertolini
Dennis Bertolini

4 August 2020 in Brazilian Journal of Microbiology
Verified
Journal Article
Open access
PDF file
MTMateus V. Thomazella
Mateus V. Thomazella
QNQuirino A. Lima Neto
Quirino A. Lima Neto
FJFrancisco F. Duarte Junior
Francisco F. Duarte Junior
FJFernando A. Jorge
Fernando A. Jorge
DMDéborah de Castro Moreira
Déborah de Castro Moreira
DBDennis Bertolini
Dennis Bertolini
Phylogenetic studies with Zika virus (ZIKV) have been conducted in Brazil. In this study, we sequenced 8 new sequences of the ZIKV envelope (E) gene from strains of cases from the Paraná and Mato Grosso do Sul states in 2016. A low phylogenetic signal was observed, with more than 40% of unresolved quartets, and the Maximum Likelihood Tree grouped all sequences in the Brazilian branches within the Asian genotype. In addition, a Shannon entropy analysis was conducted, showing a high stability in the E protein through the ZIKV polyprotein. Taken together, these results suggest a high degree of conservation in the ZIKV E gene from the recent American outbreaks.

21 February 2026 in Reviews in Medical Virology
Verified
Journal Article
Open access
HMHeloise Skiavine Madeira
Heloise Skiavine Madeira
ABAline Ávila Brustolin
Aline Ávila Brustolin
MAMarcos Elias da Silva Almeida
Marcos Elias da Silva Almeida
MRMaiara Vanusa Guedes Ribeiro
Maiara Vanusa Guedes Ribeiro
RARaul Gomes Aguera
Raul Gomes Aguera
JTJorge Juarez Vieira Teixeira
Jorge Juarez Vieira Teixeira
No laboratory test performed to date provides an absolute guarantee for detecting infectious agents. Nucleic acid amplification techniques/tests (NAT) associated with serological tests can increase safety and provide greater diagnostic accuracy for patients. We investigated the added safety of NAT technology combined with serological tests for screening blood donors for Hepatitis C virus (HCV), human immunodeficiency virus (HIV) and hepatitis B virus (HBV). Data were obtained from a systematic search conducted up until march 30, 2024 in five electronic databases: PubMed, Web of Science, Scopus, Embase , and the Cochrane library . Twenty‐nine studies, published between 1998 and 2023, were included in the review. Notably, HBV infection was predominant among donors with positive NAT results, with 425 cases, including 373 with positive serology and 52 with negative serology. Data from the diagnostic window period (WP) indicated the highest number of HBV infection cases, with 154 reported. Of the 29 included studies, 10 reported cases of occult HBV infection and diagnostic WP infection. Thirteen studies identified donors during the occult HBV infection period, and 17 identified WP cases. Meta‐analyses of positive NAT results following negative serological screening for HBV, HCV, and HIV revealed a significantly pooled frequency ( p < 0.001). Positive NAT results retrieved from donors with negative serological HBV and HCV showed a significantly combined frequency ( p < 0.001), while for HIV occurs the opposite ( p = 0.085). For HBV, HBC and HIV serological tests and NAT‐positive results, the pooled frequency was significantly ( p < 0.001). The findings demonstrate the positive relationship and safety of molecular technology in screening blood donors for HBV, HCV, and HIV using serological tests. Molecular testing remains a valuable tool for detecting and elucidating bloodborne infections.

5 December 2024 in Brazilian Journal of Microbiology
Verified
Journal Article
Closed access
PDF file
LSLéo Shigueki Sato
Léo Shigueki Sato
DMDeborah de Castro Moreira
Deborah de Castro Moreira
SMSonia Kaori Miyamoto
Sonia Kaori Miyamoto
LLLuciana Dias Ghiraldi Lopes
Luciana Dias Ghiraldi Lopes
DBDennis Bertolini
Dennis Bertolini

1 January 2022 in Revista da Sociedade Brasileira de Medicina Tropical
Verified
Journal Article
Open access
CHCláudio Queniti Hirai
Cláudio Queniti Hirai
DMDeborah de Castro Moreira
Deborah de Castro Moreira
DGDanielle Cristina Tita Granzotto
Danielle Cristina Tita Granzotto
ESEniuce Menezes De Souza
Eniuce Menezes De Souza
JTJorge Juarez Vieira Teixeira
Jorge Juarez Vieira Teixeira
DBDennis Bertolini
Dennis Bertolini
Many human immunodeficiency virus (HIV) and syphilis co-infected patients are not diagnosed, which may evolve into asymptomatic neurosyphilis (ANS). We studied the occurrence of ANS an HIV-infected population. This was a cross-sectional study of cerebrospinal fluid (CSF) samples collected from patients co-infected with HIV and Treponema pallidum. Social-demographic and clinical-laboratory characteristics were studied. Of the 348 patients infected with HIV, 33 (9.5%) had reagent treponemic and non-treponemic tests. CSF was collected from 19 asymptomatic patients. Of these, 8 (42.1%) presented with laboratory alterations suggestive of ANS. Social-demographic and clinical-laboratory variables should be considered for the indication of CSF collection.

7 August 2025 in Brazilian Journal of Microbiology
Verified
Journal Article
Closed access
PDF file
LSLéo Shigueki Sato
Léo Shigueki Sato
VFVitória Belucci Frachinconi
Vitória Belucci Frachinconi
DMDeborah de Castro Moreira
Deborah de Castro Moreira
OMOséias da Silva Martinuci
Oséias da Silva Martinuci
LLLuciana Dias Ghiraldi Lopes
Luciana Dias Ghiraldi Lopes
DBDennis Bertolini
Dennis Bertolini